DEF: Definitive Healthcare Annual Meeting: Director Elections & Equity Plan

Definitive Healthcare Corp. is holding its 2026 Annual Meeting of Stockholders on June 4, 2026, to elect directors, ratify auditors, and approve an amendment to its equity incentive plan.

Summary

• The 2026 Annual Meeting of Stockholders for Definitive Healthcare Corp. will be held on June 4, 2026, at 2:00 PM ET in Framingham, MA.
• Key items on the agenda include the election of three Class II directors for three-year terms, ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026, and approval of an amendment to the 2021 Equity Incentive Plan to increase the authorized shares by 15,000,000.
• Stockholders of record as of April 13, 2026, are eligible to vote.
• The meeting will also include an advisory vote on the compensation of Named Executive Officers (NEOs).
• Proxy materials are being made available online, with options to vote via Internet, telephone, or mail.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting standard corporate governance practices and a proactive approach to talent management through equity incentives, with no immediate negative financial indicators presented.

Positives

• The company is holding its annual meeting to ensure shareholder engagement and governance oversight.
• The proposed amendment to the equity incentive plan aims to attract, retain, and motivate key personnel, aligning their interests with stockholders.
• The board recommends voting in favor of all proposals, indicating management's confidence in its strategic direction and executive team.
• The company continues to engage with its independent auditors, Deloitte & Touche LLP, for fiscal year 2026, suggesting a stable and ongoing relationship.

Negatives

• The proposed increase in the equity incentive plan shares could dilute existing shareholders if not managed effectively.
• The advisory vote on executive compensation, while advisory, can signal shareholder sentiment regarding pay practices.

Risks

• The potential for dilution from the increased share pool under the equity incentive plan.
• The advisory vote on executive compensation could indicate shareholder dissatisfaction if a significant number of votes are cast against it.

Future Outlook

The company is seeking stockholder approval to increase the number of shares available under its 2021 Equity Incentive Plan, indicating a continued strategy of using equity-based compensation to attract, retain, and motivate employees and align their interests with stockholders for future growth.

Management Comments

• We urge you to read the accompanying materials regarding the matters to be voted on at the Annual Meeting and to submit your voting instructions by proxy.
• Whether or not you plan to attend the Annual Meeting, your vote is important to us.
• We believe that our long-term incentive compensation program aligns the interests of management, employees and the stockholders to create long-term stockholder value.
• The Company believes the Plan is best designed to provide the proper incentives for our employees, directors and consultants, ensures our ability to make performance-based awards, and meets the requirements of applicable law.

Industry Context

StockSavvy.ai notes that the proposed increase in the equity incentive plan shares is a common practice for growth-oriented technology companies seeking to remain competitive in talent acquisition and retention. The focus on aligning executive and stockholder interests through equity compensation is a standard industry approach.

Comparison to Industry Standards

• The proposed increase of 15,000,000 shares to the 2021 Equity Incentive Plan, bringing the total to 45,972,789 shares, is a significant but not unusual request for a company of Definitive Healthcare's stage, aiming to fuel future growth and talent acquisition.
• The ratification of Deloitte & Touche LLP as auditor is standard practice and aligns with the industry norm of engaging large, reputable accounting firms for public company audits.
• The advisory vote on executive compensation is a mandated practice under the Dodd-Frank Act, allowing shareholders to provide feedback on compensation philosophies and practices, a common governance mechanism across the industry.

Corporate Governance

Related Party Transactions

• The filing details various relationships and transactions with related parties, including those with affiliates of Advent International and Spectrum Equity, and Jason Krantz.
• These include nominating agreements, a tax receivable agreement, and a voting agreement with Advent.
• A master services agreement with Encora Digital, LLC, where Advent holds a majority voting interest in Encora's parent company, is also disclosed.

Stakeholder Impact

• Shareholders: The equity plan amendment could lead to dilution, but also aims to enhance long-term value. The advisory vote on executive compensation provides a mechanism for shareholder feedback.
• Employees: The equity plan amendment is intended to attract, retain, and motivate employees and officers.
• Directors: The election of directors ensures continued governance oversight.
• Management: Executive compensation is subject to advisory shareholder approval.

Next Steps

• Stockholders to vote on the proposed items at the Annual Meeting on June 4, 2026.
• The Board of Directors will act on any director resignation recommendations within 90 days of election results publication.
• The company will continue to oversee ESG matters through its Board and committees.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or significant strategic shifts that would warrant a buy or sell recommendation. The proposals are standard for corporate governance and compensation practices. A 'hold' recommendation is appropriate pending further financial disclosures or strategic developments.

Keywords

Definitive Healthcare, Proxy Statement, Annual Meeting, Director Election, Equity Incentive Plan, Executive Compensation, Independent Auditor, Stockholder Vote, Corporate Governance